Asthma control, inhalers High doses of inhaled corticosteroids were associated with lower levels of eosinophils, which may interfere with the recommendation of some monoclonal antibodies in asthma ...

In patients with asthma, stepping up to high-dose inhaled corticosteroids (ICS) was not effective in preventing future asthma exacerbations. Findings support the current Global Initiative for Asthma ...

A phase 4 study found severe asthma can be controlled using biologic therapies, without the addition of high-dose inhaled steroids. Among a cohort of patients with severe asthma using the biologic ...

Patients with type 2-high asthma who were being treated with high-dose inhaled corticosteroids (ICS) had reduced exacerbations and improved lung function when they were switched to dupilumab. Patients ...

A landmark study has shown that severe asthma can be controlled using biologic therapies, without the addition of regular high-dose inhaled steroids which can have significant side effects. The ...

Most patients with severe asthma who were treated with the biologic therapy benralizumab were able to reduce their dose of inhaled corticosteroid (ICS), and more than half could stop steroid use ...

Inhaled corticosteroids may raise a person’s risk of developing diabetes by as much as 64% when high doses are used, according to a study recently published in The American Journal of Medicine. In a ...

Please provide your email address to receive an email when new articles are posted on . 96% of patients maintained reductions through 48 weeks. 91% of patients had no exacerbations while tapering ...

Please provide your email address to receive an email when new articles are posted on . Inhaled corticosteroids were associated with lower odds for mortality in patients with COPD. An eosinophil count ...

Taking oral or inhaled glucocorticoids, a type of steroid used to curb inflammation in asthma and other autoimmune disorders, may be linked to damaging changes in the white matter of the brain, a new ...